Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 23- Open
- $91.61
- 52-wk high
- $96.29
- High
- $92.27
- 52-wk low
- $72.30
- Low
- $89.75
- Prev close
- $89.83
Smart money
Earnings
Earnings came in 6.8% above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.55B | $1.57B | $1.65B | $1.74B |
| Cost of what it sold | $345.2M | $340.6M | $359.3M | $390.6M |
| Gross profit | $1.21B | $1.23B | $1.29B | $1.35B |
| What it spent | ||||
| Research and development | $280.7M | $267.7M | $263.3M | $278.9M |
| Sales and admin | $514.6M | $602.9M | $522.2M | $561.2M |
| Other operating costs | -$10.8M | -$11.9M | -$10.9M | -$9.2M |
| Total operating expenses | $784.5M | $858.7M | $774.6M | $830.9M |
| What was left | ||||
| Operating profit | $425.1M | $370.3M | $514.7M | $519.5M |
| Profit before tax | $348.4M | $90.4M | $459.0M | $519.8M |
| Tax | $56.1M | $26.2M | $78.3M | $278.4M |
| Net profit | $291.1M | $91.2M | $380.7M | $241.9M |
| EBITDA | $387.6M | $133.1M | $499.9M | $519.5M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
News
What the news says
Coverage is bullish
Tone of tracked coverage
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
Leans bullishAug 21Tocqueville Asset Management L.P. Makes New $5.37 Million Investment in Edwards Lifesciences Corporation $EW
NeutralAug 21Bank of New York Mellon Corp Takes Position in Edwards Lifesciences Corporation $EW
NeutralAug 21